96 related articles for article (PubMed ID: 20463291)
21. Simvastatin and GGTI-2133, a geranylgeranyl transferase inhibitor, increase erythrocyte deformability but reduce low O(2) tension-induced ATP release.
Clapp KM; Ellsworth ML; Sprague RS; Stephenson AH
Am J Physiol Heart Circ Physiol; 2013 Mar; 304(5):H660-6. PubMed ID: 23335799
[TBL] [Abstract][Full Text] [Related]
22. Simvastatin impairs smad-3 phosphorylation and modulates transforming growth factor beta1-mediated activation of intestinal fibroblasts.
Burke JP; Watson RW; Murphy M; Docherty NG; Coffey JC; O'Connell PR
Br J Surg; 2009 May; 96(5):541-51. PubMed ID: 19358180
[TBL] [Abstract][Full Text] [Related]
23. Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells.
Li M; Li Z; Sun X
Eur J Pharmacol; 2008 Sep; 591(1-3):219-23. PubMed ID: 18619957
[TBL] [Abstract][Full Text] [Related]
24. Effect of HMG-CoA Reductase Inhibition on Vascular Smooth Muscle Cells Extracellular Matrix Production: Role of RhoA.
Palomino-Morales R; Perales S; Torres C; Linares A; Alejandre MJ
Curr Vasc Pharmacol; 2016; 14(4):345-52. PubMed ID: 26924327
[TBL] [Abstract][Full Text] [Related]
25. Effect of pitavastatin on transactivation of human serum paraoxonase 1 gene.
Ota K; Suehiro T; Arii K; Ikeda Y; Kumon Y; Osaki F; Hashimoto K
Metabolism; 2005 Feb; 54(2):142-50. PubMed ID: 15690306
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of prenyltransferase activity by statins in both liver and muscle cell lines is not causative of cytotoxicity.
Gee RH; Spinks JN; Malia JM; Johnston JD; Plant NJ; Plant KE
Toxicology; 2015 Mar; 329():40-8. PubMed ID: 25578243
[TBL] [Abstract][Full Text] [Related]
27. Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products.
Liang YJ; Shyu KG; Wang BW; Lai LP
Cardiology; 2008; 110(3):182-90. PubMed ID: 18057884
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho.
Kusama T; Mukai M; Tatsuta M; Nakamura H; Inoue M
Int J Oncol; 2006 Jul; 29(1):217-23. PubMed ID: 16773203
[TBL] [Abstract][Full Text] [Related]
29. Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-rho kinase pathways.
Nagaoka T; Hein TW; Yoshida A; Kuo L
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):825-32. PubMed ID: 17251484
[TBL] [Abstract][Full Text] [Related]
30. Geranylgeranyl transferase 1 modulates autophagy and apoptosis in human airway smooth muscle.
Ghavami S; Mutawe MM; Schaafsma D; Yeganeh B; Unruh H; Klonisch T; Halayko AJ
Am J Physiol Lung Cell Mol Physiol; 2012 Feb; 302(4):L420-8. PubMed ID: 22160308
[TBL] [Abstract][Full Text] [Related]
31. Plasminogen activation by airway smooth muscle is regulated by type I collagen.
Schuliga M; Harris T; Stewart AG
Am J Respir Cell Mol Biol; 2011 Jun; 44(6):831-9. PubMed ID: 20693403
[TBL] [Abstract][Full Text] [Related]
32. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
33. HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells.
Kagami S; Kanari H; Suto A; Fujiwara M; Ikeda K; Hirose K; Watanabe N; Iwamoto I; Nakajima H
Int Arch Allergy Immunol; 2008; 146 Suppl 1():61-6. PubMed ID: 18504409
[TBL] [Abstract][Full Text] [Related]
34. Simvastatin inhibits glucose-stimulated vascular smooth muscle cell migration involving increased expression of RhoB and a block of Ras/Akt signal.
Chan KC; Wu CH; Huang CN; Lan KP; Chang WC; Wang CJ
Cardiovasc Ther; 2012 Apr; 30(2):75-84. PubMed ID: 20946258
[TBL] [Abstract][Full Text] [Related]
35. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA.
Tang D; Park HJ; Georgescu SP; Sebti SM; Hamilton AD; Galper JB
Life Sci; 2006 Sep; 79(15):1484-92. PubMed ID: 16740276
[TBL] [Abstract][Full Text] [Related]
36. Protein isoprenylation regulates secretion of matrix metalloproteinase 1 from rheumatoid synovial fibroblasts: effects of statins and farnesyl and geranylgeranyl transferase inhibitors.
Abeles AM; Marjanovic N; Park J; Attur M; Chan ES; Al-Mussawir HE; Dave M; Fisher MC; Stuchin SA; Abramson SB; Pillinger MH
Arthritis Rheum; 2007 Sep; 56(9):2840-53. PubMed ID: 17763406
[TBL] [Abstract][Full Text] [Related]
37. Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells.
Camino-López S; Llorente-Cortés V; Sendra J; Badimon L
Cardiovasc Res; 2007 Jan; 73(1):208-16. PubMed ID: 17141748
[TBL] [Abstract][Full Text] [Related]
38. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
Lee MH; Cho YS; Han YM
Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin.
Louneva N; Huaman G; Fertala J; Jiménez SA
Arthritis Rheum; 2006 Apr; 54(4):1298-308. PubMed ID: 16575855
[TBL] [Abstract][Full Text] [Related]
40. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.
Blanco-Colio LM; Muñoz-García B; Martín-Ventura JL; Lorz C; Díaz C; Hernández G; Egido J
Circulation; 2003 Sep; 108(12):1506-13. PubMed ID: 12952848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
